Optimal clinical pathway for adults with neurological autoimmune diseases

There is a wide spectrum of multisystem neurological autoimmune disorders, with a great deal of immunomodulatory drugs with specificities for different conditions. As such, knowledge required to treat conditions is great and the diagnosis must be exact to deliver the correct care.

Download the optimal clinical pathway here.

Neuroimmunology patients require support from a wide range of services. In addition to general and specialist neurologists, patients with neurological autoimmune diseases are seen by a range of healthcare professionals, including other specialists such as dermatologists, rheumatologists, nephrologists and chest physicians (in the case of multisystem disorders) and general practitioners (in the case of chronic care) – often with little support and advice on management of rare conditions. This can lead to variation in patient care and quality, including getting an accurate diagnosis in a timely manner and entering the correct treatment pathway.

The optimal pathway for patients with neurological autoimmune disease outlines:

• The “optimal” pathway for patients with neurological autoimmune diseases, from first neurological symptoms to ongoing management

• The definition of “specialist” neuroimmunology care

• Efficiencies and improved outcomes

• Barriers and potential solutions around patient flow and investigation cost, access to new therapies, research and clinical trials and diagnostic tests

MS is excluded from consideration in this pathway and is considered in the optimal clinical care pathway for adults with MS (in development).

Download the optimal clinical pathway here.

The cross-cutting theme pathways should be viewed alongside this pathway.